itraconazole has been researched along with Malaria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida-Paes, R; Almeida-Silva, F; Alves, GM; Amaral, ACF; Brito-Santos, F; Coelho, RA; de Souza, GR; Figueiredo-Carvalho, MHG; Lourenço, MCDS | 1 |
| Cortopassi, WA; França, TC; Krettli, AU; Oliveira, AA; Penna-Coutinho, J | 1 |
2 other study(ies) available for itraconazole and Malaria
| Article | Year |
|---|---|
New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Topics: Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Malaria; Microbial Sensitivity Tests; Phaeohyphomycosis; Terbinafine | 2022 |
Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
Topics: Animals; Antimalarials; Atorvastatin; Catalytic Domain; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; L-Lactate Dehydrogenase; Malaria; Mice; Plasmodium falciparum; Pyrroles; Triazoles | 2011 |